cobimetinib,vemurafenib
roche,exelixis
['3008', 'cobimetinib', 'vemurafenib']
 our study demonstrated that braf v600 mutations are drivers and that the combination of cobimetinib and vemurafenib has antitumor activity in a variety of tumor types, says dr. funda meric-bernstam. learn more about #asco22 abstract 3008: #endcancer 
Driven by our mission to #EndCancer, MD Anderson is a leader in cancer care, research, education and training, and prevention. Appointments: 1-877-632-6789